Inhibiting thromboinflammation with a designed peptide that blocks the IL-1β-FXIa axis uncouples antithrombosis from bleeding risk
Open Access
- 15 April 2026
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Abstract
The complex interplay between inflammation and coagulation drives thromboinflammatory disorders. While previous studies have shown that interleukin-1β (IL-1β) can induce a hypercoagulable state in response to tissue hypoxia and inflammation, the specific mechanisms of its action on the coagulation cascade remain unclear. Here, we demonstrate that IL-1β directly potentiates key coagulation factors (FXIa, FXa, thrombin, and kallikrein) to accelerate thrombosis. Mechanistically, IL-1β enhances FXIa enzymatic activity through specific binding to its exosite domain. Additionally, we established an IL-1β-FXIa interaction model, based on which the inhibitory peptide QK10 was derived to specifically disrupt their interaction interface and effectively block IL-1β's potentiation of FXIa. Critically, in multiple thrombosis models, QK10 exhibited significant antithrombotic efficacy at doses equal to low molecular weight heparin (LMWH). Notably, bleeding assays revealed a significantly lower bleeding risk with QK10 compared to LMWH. Notably, QK10 also demonstrated promising anti-stroke efficacy in ischemic stroke models. Taken together, these findings establish QK10 as a viable therapeutic candidate that targets the IL-1β-FXIa prothrombotic axis for disruption, features enhanced safety, and offers a new approach to treating thrombo-inflammatory conditions, including ischemic stroke.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2023YQ025)
- Natural Science Foundation of Shandong Province (ZR2025ZD03)
- Natural Science Foundation of Shandong Province (ZR2024QH554)
- National Natural Science Foundation of China (32371162)
- Start-up funding from Qingdao University (DC2300000302)
- Shandong Provincial Postdoctoral Science Foundation (SDCX-ZG-202400149)
- Taishan Scholars Program for Young Experts of Shandong Province (tsqn202312177)
- Key R&D Program of Shandong Province (2025CXPT137)
- National Undergraduate Training Program for Innovation and Entrepreneurship (202411065011)
This publication has 55 references indexed in Scilit:
- Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolutionImmunity, 2025
- Structure-based design and synthesis of novel FXIa inhibitors targeting the S2' subsite for enhanced antithrombotic efficacyMolecular Diversity, 2024
- Innate immune memory after brain injury drives inflammatory cardiac dysfunctionCell, 2024
- Bleeding Risk in Asian PatientsJACC: Asia, 2024
- Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8Cytokine, 2018
- Recent advances in the discovery and development of factor XI/XIa inhibitorsMedicinal Research Reviews, 2018
- Mechanical and Biochemical Role of Fibrin Within a Venous ThrombusEuropean Journal of Vascular and Endovascular Surgery, 2018
- Targeting platelet receptor function in thrombus formation: The risk of bleedingBlood Reviews, 2014
- Activation of thromboxane receptor modulates interleukin-1β-induced monocyte adhesion―A novel role of Nox1Free Radical Biology and Medicine, 2012
- Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human SepsisArchives of Surgery, 1995